Celcuity Share Price

Celcuity Share Price

NASDAQ: CELC | Mid Cap | Healthcare
$53.40
-$2.89 (-5.13%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Celcuity Stock Performance

Open
$55.26
Prev. Close
$56.29
Circuit Range
N/A
Day Range
$53.22 - $57.00
Year Range
$53.22 - $151.01
Volume
31,591
Average Traded
$54.51

Celcuity Share Price Today

As of 21 November 2026, Celcuity Inc.'s share price is $53.40. The stock opened at $55.26, compared to its previous close of $56.29. During today's trading session, Celcuity Inc.'s share price traded between $53.22 and $57.00, with an average price of $55.11. Over the past 52 weeks, the stock has recorded a high of $151.01 and a low of $53.22. In terms of performance, Celcuity Inc.'s share price has declined by 59.73% over the last six months and is down 47.21% on a year-on-year basis.

Celcuity Share Price Chart

Line chart of the Celcuity price trend over the selected period. The price fell overall, ranging from 53.22 to 57.00, ending at 53.40.
$53.22$57.00
L
Show Current Price
H

Celcuity Stock Fundamentals & Key Indicators

Market Cap
$2.50B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-5.23
Revenue (TTM)
$0.00
Return On Equity (TTM)
345.78%
Profit Margin
N/A
Debt to Equity
-10.18
Quarterly Earnings Growth YoY
-43.89%

Celcuity Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$50.97-$52.84-$78.86-$73.34
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-3.67%-49.24%7.00%

Celcuity Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$40.37-$63.78-$111.78-$177.04
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-57.99%-75.26%-58.38%

Celcuity Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.90.550.630.51
Current Assets465.66244.57190.59175.19
Total Assets466.56245.12191.22175.7
Non Current Liabilities321.8597.7837.2635.04
Current Liabilities44.1531.7214.196.88
Total Liabilities366.0129.551.4541.93
Shareholders' Equity100.56115.62139.77133.77

Celcuity Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-153.28-83.47-53.81-36.01
Investing-64.08-63.07-5.01-144.03
Financing360.55138.3964.91120.33

About Celcuity

Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offering comprehensive inhibition with a mechanism and pharmacokinetics differentiated from other therapies. The Phase 3 VIKTORIA-1 trial, evaluating gedatolisib with fulvestrant, with or without palbociclib, in HR+/HER2- breast cancer, has completed enrollment and reported results for PIK3CA WT tumors, with cohort 2 (PIK3CA MT) also enrolled. Phase 3 VIKTORIA-2 and Phase 1b/2 CELC-G-201 trials, evaluating combinations in endocrine-resistant HR+/HER2- breast cancer and metastatic castration-resistant prostate cancer, are ongoing.

Celcuity Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$69.43
$53.34
-22.92%
Oct 2026
$78.93
$69.19
-13.10%
Sep 2026
$90.94
$79.62
-14.67%
Aug 2026
$84.91
$93.31
+7.89%
Jul 2026
$105.78
$86.48
-17.41%
Jun 2026
$130.32
$104.71
-21.04%
May 2026
$120.75
$132.61
+9.27%
Apr 2026
$117.56
$121.36
+6.40%
Mar 2026
$110.89
$114.06
+2.08%
Feb 2026
$111.14
$111.74
+2.13%
Jan 2026
$99.71
$109.41
+9.80%
Dec 2025
$100.25
$99.64
-1.51%

Celcuity Share Price FAQs